|

Scientific Programme
Preliminary programme (PDF) 
Wednesday 23 June 2010 |
| |
|
|
| 14.00 – 16.00 |
|
EVF Executive meeting |
| |
|
|
| 17.00 – 19.00 |
|
EVF Board meeting |
| |
| |
Thursday 24 June 2010 |
| |
|
|
| 07.00 – 09.30 |
|
Set up exhibition |
| |
|
|
| 09.00 – 10.30 |
|
Registration & coffee/tea/refreshments |
| |
|
|
| 10.30 – 10.35 |
|
Welcome
Marianne De Maeseneer, President, European Venous Forum |
| |
|
|
| 10.35 – 12.30 |
|
7th North Sea Meeting on Venous Diseases
(organised by the Benelux Society of Phlebology)
Long-term follow-up after varicose veins treatment
Chair: André van Rij, Cees Wittens |
| 10.35 – 10.50 |
|
Let’s learn something more about statistics
Alun Davies, London, UK |
| 10.50 – 11.10 |
|
What are the long-term outcomes that matter?
Jonothan Earnshaw, Gloucester, UK |
| 11.10 – 11.30 |
|
Long-term follow-up after surgical treatment of varicose veins
Cees Wittens, Maastricht, The Netherlands |
| 11.30 – 11.50 |
|
Long term outcomes after endovenous treatment for varicose veins
Manj Gohel, London, UK |
| 11.50 – 12.10 |
|
Long-term results after redo procedures for recurrent varicose veins
Marianne De Maeseneer, Antwerp, Belgium |
| 12.10 – 12.30 |
|
Defining outcomes: Pitfalls and possibilities
André van Rij, Dunedin, New Zealand |
| |
|
|
| 12.30 – 13.00 |
|
General assembly of the Benelux Society of Phlebology
(only for members of BSP) |
| |
|
|
| 12.30 – 13.30 |
|
Lunch |
| |
|
|
| 13.30 – 14.50 |
|
Prevention of venous thromboembolism (VTE) in 2010: an update
Chair: Niels Baekgaard, Ajay Kakkar |
| 13.30 – 13.50 |
|
Risk assessment as a guide to thrombosis prophylaxis.
Joe Caprini, Chicago, USA |
| 13.50 – 14.10 |
|
New perspectives in pharmacologic prophylaxis
Ajay Kakkar, London, UK |
| 14.10 – 14.30 |
|
Intermittent pneumatic compression and combined modalities for VTE prevention in high risk patients
Andrew Nicolaides, Nicosia, Cyprus |
| 14.30 – 15.30 |
|
Treatment of VTE: improving the long-term outcome
Chair: Niels Baekgaard, Ajay Kakkar |
| 14.30 – 14.50 |
|
Advances in anticoagulant treatment of VTE
Russell Hull, Calgary, Canada |
| 14.50 – 15.10 |
|
Generic and biosimilar anticoagulants; what does the future hold?
Jawed Fareed, Loyola University, Maywood, IL, USA |
| 15.10-15.30 |
|
Long-term results after catheter-directed thrombolysis for iliofemoral deep vein thrombosis
Anthony Comerota, Toledo, Ohio, USA |
| |
|
|
| 15.30 - 16.00 |
|
Coffee break / Visit of exhibition |
| |
|
|
| 16.00-17.15 |
|
Invited Presentations
Chair: Joe Caprini, Bo Eklof |
| 16.00 – 16.40 |
|
Presentations from the American Venous Forum (Servier Award Travelling Fellowship winners) |
| |
Paper No |
| 16.00 – 16.20 |
A1 |
Post thrombotic vein wall remodeling: preliminary findings.
K Deatrick, N Baker, S DeRoo, MA Elfline, V Sood, C Stabler, SA Blackburn, CE Luke, TW Wakefield, PK Henke. University of Michigan, Ann Arbor, MI, USA |
| 16.20 – 16.40 |
A2 |
Validation of the Caprini Risk Assessment Model in Plastic and Reconstructive Surgery Patients.
CJ Pannucci(1), S Bailey (2), C Fisher(3), J Clavijo-Alvarez (3), J Hamill
(4), K Hume(4), T Wakefield (1), J Rubin (3), E Wilkins (1), R Hoxworth(2).
(1) University of Michigan, Ann Arbor, MI,
(2) University of Texas-Southwestern, Dallas, TX,
(3) University of Pittsburgh, Pittsburgh, PA,
(4) American Society of Plastic Surgeons, Arlington Heights, IL, USA |
| 16.40 – 17.00 |
A3 |
Presentation from the EVF Travelling Fellowship 2009
Incidence of secondary interventions after endovenous laser therapy and
minimal phlebectomies for the treatment of varicose veins.
G Sfyroeras. Department of Vascular Surgery, University Hospital of Larissa, Larissa, Greece |
| 17.00 – 17.15 |
|
Reduction of venous ulcers by 50% in ten years in the US – is that feasible? Report from the 6th Pacific Vascular Symposium in Hawaii November 2009
Bo Eklof. Sweden |
| 17.15-18.00 |
|
Duplex ultrasound scan in phlebologic practice: tips and tricks (life cases)
Nicos Labropoulos, Stony Brook, New York, USA |
| |
|
|
| 18.00 – 19.15 |
|
Session 1. Short Papers (5 min + 10 min discussion) |
| |
Paper No |
| 18.00 |
1.1 |
Surgical treatment for varicose recurrence: Is inguinal redo surgery justified?
Pittaluga P1,2, Chastanet S1,2, Locret T1, Rousset O2.
1 Riviera Veine Institut, Nice, France. 1 -IM2S, Monte-Carlo, Monaco |
| 18.15 |
1.2 |
Quality assurance of venous duplex scans performed by a vascular surgeon.
Kordowicz A, Ferguson G, Salaman R, Onwudike M.
Department of Vascular Surgery, Royal Bolton Hospital, England
Submitted in consideration for the EVF Prize |
| 18.30 |
1.3 |
Analyzing exhaled breath during endovenous laser ablation of varicose veins using an electronic nose and gas chromatography-mass spectrometry.
Gauw SA, Fens N, Knobel HH, Bokx de PK, Vlijmen van CJ, Sterk PJ.
Flebologisch Centrum Oosterwal, Alkmaar, The Netherlands.
Department of Pulmonology, Academic Medical Centre, Amsterdam, The Netherlands.
MiPlaza TMA, Philips Research Europe, Eindhoven, The Netherlands |
| 18.45 |
1.4 |
Pharmacodynamic differences between biosimilar and branded enoxaparins with reference to their immunogenic profile.
Ramacciotti E, Rao G, Hoppensteadt D, Jeske W, Walanga JM, Fareed J.
Pathology, Loyola University Medical Center, Maywood, IL, United States of America. University of Michigan, Ann Arbor, MI, USA |
| 19.00 |
1.5 |
Microfoam sclerotherapy as a part of multimodality treatment in patients with venous malformations.
Sapelkin SV, Dan VN, Vetyugova LV.
Vishnevsky Institute of Surgery,Moscow, Russia
Submitted in consideration for the EVF Prize |
|
| |
|
|
| 19.30 – 21.00 |
|
Welcome reception at exhibition area |
| |
|
Friday 25 June 2010 |
| |
|
|
| 08.00 – 08.30 |
|
Registration & coffee/tea/refreshments |
| |
|
|
| 08.25 |
|
Welcome
Andrew Nicolaides, Chairman of the European Venous Forum |
| |
|
|
| 8.30 – 10.30 |
|
Session 2: Clinical and Basic Research(6 papers: 10 min + 10 min discussion)
Chair: Andrew Nicolaides, Marianne de Maeseneer |
| |
Paper No |
| 08.30 |
2.1 |
Reproducibility of lower limb venous reflux assessed by ultrasound
duplex scanning using manual and pneumatic cuff compression in
patients with chronic venous disease and controls.
Broholm R, Jensen LP, Sillesen H, Bækgaard N.
Department of Vascular Surgery, Rigshospitalet, Department at Gentofte Hospital, University of
Copenhagen, Denmark.
Submitted in consideration for the EVF Prize |
| 08.50 |
2.2 |
Perforator incompetence and associated patterns of saphenous reflux in
primary chronic venous disease.
Qureshi MI, McDonald A, Wing L, Lim CS, Gohel M, Ellis M, Franklin IJ, Davies AH.
Imperial Vascular Unit, Charing Cross Hospital, Imperial College London, United Kingdom
Submitted in consideration for the EVF Prize |
| 09.10 |
2.3 |
Lower limb venous blood flow by Magnetic Resonance Imaging during
Intermittent Pneumatic Compression of the Calf and Foot.
Pierce I1,3, Kalodiki E2,3, Lattimer C2,3, Geroulakos G2,3, Gatehouse PD1,3, Firmin DN1,3.
Cardiovascular MR Unit Royal Brompton Hospital Trust1,
Vascular Unit Ealing Hospital2, Imperial College London3
Submitted in consideration for the EVF Prize |
| 09.30 |
2.4 |
Tissue pressures in venous disease.
Gemayel G, Christenson JT.
Division of Cardiovascular Surgery, Venous Centre, University Hospital of Geneva & Faculty of Medicine, University of Geneva, Geneva, Switzerland
Submitted in consideration for the EVF Prize |
| 09.50 |
2.5 |
Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors.
Pollice F, Pollice P, Groehe B.
University of Berne, Department of Cardiology and Biology, Switzerland |
| 10.10 |
2.6 |
Steam ablation of saphenous varicose veins: A promising new endovenous thermal therapy.
van den Bos RR, Milleret R, Neumann M, Nijsten T. Erasmus MC, Rotterdam,
The Netherlands
Submitted in consideration for the EVF Prize |
|
| |
|
|
| 10.30 – 11.00 |
|
Coffee break / Visit of exhibition |
| |
|
|
| 11.00 – 12.20 |
|
Long-term oedema needs long-term compression
Chair: Hugo Partsch, Karin van der Wegen |
| 11.00 – 11.20 |
|
Compression to control oedema: Bandages or stockings?
Giavanni Mosti, Lucca, Italy |
| 11.20 – 11.40 |
|
What about occupational oedema?
Hugo Partsch, Vienna, Austria |
| 11.40 – 12.00 |
|
What about post-thrombotic oedema?
Martino Neumann, Rotterdam, The Netherlands |
| 12.00 – 12.20 |
|
What about lymphoedema?
Robert Damstra, Drachten, The Netherlands |
| |
|
|
| 12.20 – 12.50 |
|
EVF Invited Lecture
Current Advances in the Treatment of Post-Thrombotic Syndrome
Russell Hull, Calgary, Canada |
| |
|
|
| 12.50 – 13.30 |
|
Lunch |
| |
|
|
| 13.30 – 15.30 |
|
Session 3. Deep Venous Problems (6 papers: 10 min + 10 min discussion)
Chair: Michel Perrin, Ivan Staelens |
| |
Paper No |
| 13.30 |
3.1 |
Perioperative bridging therapy in surgical patients with high risk of
thromboembolic and haemorrhagic complications on long term
acenokumarol therapy.
Wiszniewski A¹, Szopiński P¹, Bilski R¹, Proniewski J², Ratajczak J³
¹Department of Vascular Surgery, Institute of Hematology and Transfusion
Medicine, Warsaw, Poland.
²Department of Radiology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
³Department of Anesthesiology and Intensive Care, Institute of Hematology and
Transfusion Medicine, Warsaw, Poland
Submitted in consideration for the EVF Prize |
| 13.50 |
3.2 |
Effect of the anticoagulant therapy in the thrombus regression: A prospective duplex ultrasound study.
Romera-Villegas A, Cairols MA, Martí-Mestre X, Riera-Batalla S, Martinez-Rico C.
Servei d’Angiologia i Cirurgia Vascular, Hospital Universitary de Bellvitge, Barcelona, Spain
Submitted in consideration for the EVF Prize |
| 14.10 |
3.3 |
A ten year experience of retrievable inferior vena cava filters.
Ahmad A1, Saha P1, Rolph R1, Patel AS1, Modarai B1, Sabharwal T2, Waltham M1. 1Department of Vascular Surgery, Guy’s and St Thomas’ NHS Foundation Trust, King’s Health Partners, London, UK.
2Department
of Interventional Radiology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK |
| 14.30 |
3.4 |
Towards a better understanding of inferior vena cava atresia.
Lauwers K, Hertoghs M, Van Schil P, De Maeseneer M.
Antwerp University Hospital, Department of Thoracic and Vascular Surgery,
Antwerp, Belgium
Submitted in consideration for the EVF Prize |
| 14.50 |
3.5 |
Stenting for chronic postthrombotic vena cava and iliofemoral venous
occlusions. Midterm patency and clinical outcome.
Rosales A1, Sandbæk G1,2, Jørgensen JJ1,2.
Dept. Of Vascular Surgery, Oslo University Hospital, Aker1,
University of Oslo, Norway2 |
| 15.10 |
3.6 |
Percutaneous occlusion in deep parallel reflux after deep venous valve reconstruction.
Maleti O, Lugli M, Guerzoni S.
Department of Cardiovascular Surgery,
Research and Management Center for Deep Vein Disorders, Hesperia Hospital, Modena, Italy |
|
| |
|
|
| 15.30 – 16.00 |
|
Coffee break |
| |
|
|
| 16.00 – 18.00 |
|
Session 4: Endovenous Treatment of Varicose Veins: Clinical Trials
Chair: Jonothan Earnshaw, Anja Sommer |
| |
Paper No |
| 16.00 |
4.1 |
A prospective recovery study after high ligation and stripping or endovenous treatment of the insufficient great saphenous vein using local anaesthesia.
Pronk P, Gauw SA, Mooij MC, Gaastra MTW, Lawson JA, van Vlijmen-van Keulen CJ. Flebologisch Centrum Oosterwal, Alkmaar, The Netherlands
Submitted in consideration for the EVF Prize |
| 16.20 |
4.2 |
Endovenous laser treatment: is there a different clinical and
morphological outcome using a 1500nm laser versus a 980 nm diode laser? A multicentric randomised comparative trial.|
Vuylsteke M (1), De BO Th (1), Dompe G (2), di Crisci D (2), Miquel Abbab C (3),
Mordon S (4).
(1) Department of Vascular Surgery, Sint-Andriesziekenhuis, Tielt, Belgium.
(2) Department of Vascular Surgery, Istituto Dermopatico Dell’Immacolata, Rome, Italy. (3) Department of Vascular Surgery, Hospital Universitari Sagrat Cor, Barcelona, Spain. (4) INSERM U703, Lille University Hospital, Lille, France |
| 16.40 |
4.3 |
Randomised clinical trial comparing VNUS Closure Fast versus laser for varicose veins (VALVV): Duplex and quality of life outcomes at 6 months.
Shepherd AC, Gohel MS, Brown LC, Davies AH.
Imperial Vascular Unit,Imperial College, London, UK
Submitted in consideration for the EVF Prize |
| 17.00 |
4.4 |
Comparison of radiofrequency and laser treatment in the same saphenous veins of the same patient.
Ragg JC, Martel L, Wolschner J, Nagy J.
Angioclinic, Berlin, Germany |
| 17.20 |
4.5 |
Duplex guided foamsclerotherapy vs surgery for the incompetent great
saphenous vein: a randomised controlled trial.
Shadid N, Nelemans P, Sommer A.
Maastricht University Medical Center
(MUMC), Maastricht, The Netherlands
Submitted in consideration for the EVF Prize |
| 17.40 |
4.6 |
Randomized trial comparing RF, Laser, foam sclerotherapy and stripping in varicose veins.
Lawaetz M, Rasmussen LH, Bjoern L, Blemings A, Eklöf B.
The Danish Vein Centres and Surgical Centre Roskilde, Naestved, Denmark
Submitted in consideration for the EVF Prize |
|
| |
|
|
| 18.00 – 18.30 |
|
General Assembly of the European Venous Forum |
| |
|
|
| 19.15 |
|
Short walk to the boat |
| |
|
|
| 19.30 – 24.00 … |
|
Dinner cruise on river Scheldt with the ‘Seastar’ |
| |
|
Saturday 26 June 2010 |
| |
|
|
| 08.00 – 9.00 |
|
Registration & coffee/tea/refreshments |
| |
|
|
| 09.00 – 11.00 |
|
Session 5. Socio-economic Implications of Chronic Venous Disease
Chair: Attilo Cavezzi, Martino Neumann |
| |
Paper No |
| 09.00 |
5.1 |
How well informed are your patients? Assessing the quality of varicose vein information for patients on the internet.
Neffendorf JE1, Soobrah R2, Grewal P3.
1University College London Hospital, London, UK.
2Northwick Park and St. Paul’s Hospitals, London,UK.
3Royal Free Hospital, London, UK
Submitted in consideration for the EVF Prize |
| 09.20 |
5.2 |
Validating veines QOL/SYM: Measuring changes following endovenous microfoam ablation of the Great Saphenous vein.
Gibson K, Wright D, Rush J, Suplick G, Evans E.
Lake Washington Vascular Surgeons, Bellevue, WA, USA |
| 09.40 |
5.3 |
Varicose vein recurrence and patient satisfaction 10-15 years following saphenous and perforator surgery.
Nelzén O,
Depts Vascular Surgery, Skaraborg Hospital/KSS, Skövde & Uppsala University, Sweden |
| 10.00 |
5.4 |
Hospital admission for venous ulcers: What is it worth?
Reeder SWI1, de Roos K-P2, de Maeseneer M3, Sommer A4, Neumann HAM1.
1Department of Dermatology, Erasmus MC, Rotterdam, The Netherlands,
2Department of Dermatology, DermaPark, Uden, TheNetherlands,
3Department of Thoracic and Vascular Surgery, University Hospital of Antwerp, Antwerp, Belgium,
4Department of Dermatology, Academic Hospital Maastricht, Maastricht, The Netherlands
Submitted in consideration for the EVF Prize |
| 10.20 |
5.5 |
Can saphenous and sural nerve paraesthesia be prevented during ELT?
King T1
1Vein Clinics of America, Oak Brook, IL, USA |
| 10.40 |
5.6 |
The cost effectiveness of the Trellis Peripheral Infusion System (“Trellis”) compared with Catheter Directed Thrombolysis or treatment with standard anticoagulation therapy for patients who are poor responders to ACT: An exploratory Markov analysis
O’Sullivan GJ. Galway
University Hospitals & National University of Ireland in Galway, Galway, Ireland |
|
| |
|
|
| 11.00 – 11. 30 |
|
Coffee break / Visit of exhibition
After break: end of exhibition |
| |
|
|
| 11.30 – 12.30 |
|
Back to basic science…
Chair: Marc Cairols, Mieke Flour |
| 11.30 – 11.50 |
|
Casting around for new ideas in venous physiology
André van Rij, Dunedin, New Zealand |
| 11.50 – 12.10 |
|
The scientific basis for the management of chronic venous disease
Anthony Comerota, Toledo, Ohio, USA |
| 12.10 – 12.30 |
|
Studying the skin in chronic venous disease
Mieke Flour, Leuven, Belgium |
| |
|
|
| 12.30 – 12.45 |
|
Musical intermezzo
Conducted by Prof Joost Weyler, University of Antwerp |
| |
|
|
| 12.45 – 13.00 |
|
Presentation of EVF prizes - farewell |
|